e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Neutrophil dysfunction in bronchiectasis: an emerging role for immunometabolism
Yan Hui Giam, Amelia Shoemark, James D. Chalmers
Source:
Eur Respir J, 58 (2) 2003157; 10.1183/13993003.03157-2020
Journal Issue:
August
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Yan Hui Giam, Amelia Shoemark, James D. Chalmers. Neutrophil dysfunction in bronchiectasis: an emerging role for immunometabolism. Eur Respir J, 58 (2) 2003157; 10.1183/13993003.03157-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
Pathogenesis of idiopathic pulmonary fibrosis: role of neutrophil inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 102s
Year: 2006
Making the case for causality: what role do lung microbiota play in idiopathic pulmonary fibrosis?
Source: Eur Respir J, 55 (4) 2000318; 10.1183/13993003.00318-2020
Year: 2020
Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy
Source: Eur Respir Rev, 31 (163) 210241; 10.1183/16000617.0241-2021
Year: 2022
Role of neutrophil mechanisms of inflammation in pathogenesis of different types of pulmonary fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 459s
Year: 2003
Epithelial pIgR: A new player in idiopathic pulmonary fibrosis?
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018
Towards precision medicine in bronchiectasis: what is the role of neutrophilic elastase determination?
Source: Eur Respir J, 53 (6) 1900765; 10.1183/13993003.00765-2019
Year: 2019
Increased neutrophil gelatinase-associated lipocalin (NGAL) promotes airway remodeling in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Source: Eur Respir J 2007; 30: 1043-1056
Year: 2007
Platelets: a potential role in chronic respiratory diseases?
Source: Eur Respir Rev, 30 (161) 210062; 10.1183/16000617.0062-2021
Year: 2021
Severe lung inflammation is a feature of IPF
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
The pathogenesis of pulmonary fibrosis: a moving target
Source: Eur Respir J 2013; 41: 1207-1218
Year: 2013
The role of monocyte inflammation and oxidant stress in the etiopathogenesis of cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 485s
Year: 2006
IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Pulmonary fibrosis: key features and challenges
Source: International Congress 2015 – PG8 Airway and lung fibrosis
Year: 2015
Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Lung inflammation in cystic fibrosis: an overlooked therapeutic target?
Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age
Year: 2020
A role for the mesothelium in restrictive chronic lung allograft dysfunction?
Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD)
Year: 2017
Neutrophil extracellular traps (NETs) in COPD: A potential novel mechanism for host damage in acute exacerbations
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept